US proposal to halve biosimilar development costs for India's Biocon, top exec says
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more
November 13, 2025
TI projects upbeat quarterly results on strong data center chip demand
ServiceNow flags Middle East deal delays, shares crash
Intel lands key first customer for chip '14A' chip tech with Tesla's Terafab project, Musk says
New Zealand's opposition Labour Party to support India free trade deal
Mexico reopens famed pyramids under heavy police presence after deadly shooting
Kennedy Center officials pledge transparency on renovations after Trump takeover
Olympics-Putin criticises previous IOC leadership as 'shameful, cowardly'